Skip to main content

Peer Review reports

From: Polypharmacy and severe potential drug-drug interactions among older adults with cardiovascular disease in the United States

Original Submission
16 Nov 2020 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
2 Feb 2021 Author responded Author comments - Marwan Sheikh-Taha
9 Dec 2020 Reviewed Reviewer Report - Lorene Zerah Zerah
26 Jan 2021 Reviewed Reviewer Report
Resubmission - Version 3
2 Feb 2021 Submitted Manuscript version 3
4 Feb 2021 Author responded Author comments - Marwan Sheikh-Taha
Resubmission - Version 4
4 Feb 2021 Submitted Manuscript version 4
4 Feb 2021 Author responded Author comments - Marwan Sheikh-Taha
Resubmission - Version 5
4 Feb 2021 Submitted Manuscript version 5
25 Feb 2021 Author responded Author comments - Marwan Sheikh-Taha
5 Feb 2021 Reviewed Reviewer Report - Lorene Zerah Zerah
Resubmission - Version 6
25 Feb 2021 Submitted Manuscript version 6
1 Mar 2021 Author responded Author comments - Marwan Sheikh-Taha
Resubmission - Version 7
1 Mar 2021 Submitted Manuscript version 7
24 Mar 2021 Author responded Author comments - Marwan Sheikh-Taha
18 Mar 2021 Reviewed Reviewer Report - Lorene Zerah Zerah
Resubmission - Version 8
24 Mar 2021 Submitted Manuscript version 8
Publishing
30 Mar 2021 Editorially accepted
7 Apr 2021 Article published 10.1186/s12877-021-02183-0

You can find further information about peer review here.

Back to article page
\